Running title: Thromboxane A 2 inhibition of SK Ca after NOS block 2 Background and purpose. NO/prostanoid independent, EDHF-mediated hyperpolarization and dilation in rat middle cerebral arteries is mediated solely by endothelial cell IK Ca . However, when the NO-pathway is also active, both SK Ca and IK Ca contribute to EDHF responses. As the SK Ca component can be inhibited by stimulation of thromboxane A 2 (TxA 2 ) TP receptors and NO has the potential ability to inhibit thromboxane synthesis, we investigated whether TxA 2 might explain loss of functional input from SK Ca during NOS inhibition in cerebral arteries.
Introduction
In rat middle cerebral arteries treated with a NO synthase (NOS) inhibitor (L-NAME), blockade of endothelial cell intermediate conductance calcium activated potassium channels (IK Ca ) alone is sufficient to block smooth muscle hyperpolarization and relaxation due to endothelium-derived hyperpolarizing factor (EDHF: (McNeish et al., 2005 , Marrelli et al., 2003 . This is in contrast to peripheral arteries, where EDHF mediated responses are only abolished by the combined inhibition of both small conductance calcium activated potassium channels (SK Ca ) and IK Ca (Busse et al., 2002) . A number of studies with peripheral arteries have provided functional, electrophysiological and immunohistochemical data showing that SK Ca and IK Ca channels are expressed only within the endothelium , Walker et al., 2001 . We recently investigated if the apparent solitary role of IK Ca in the EDHF response of rat middle cerebral arteries reflected an absence of SK Ca channels. Surprisingly in the light of the functional data, but in common with peripheral arteries, both IK Ca and SK Ca channels were demonstrated in the endothelium (McNeish et al., 2006) .
The relative contribution from SK Ca and IK Ca channels to the EDHF response is altered by arterial stimulation. In rat mesenteric arteries, during smooth muscle contraction evoked by phenylephrine, block of endothelium-dependent hyperpolarization and relaxation requires inhibition of both endothelial SK Ca and IK Ca , but in unstimulated vessels (where there is no contraction to reverse) inhibition of SK Ca alone is sufficient to block EDHF-mediated hyperpolarization (Crane et al., 2003) . In contrast to mesenteric arteries, arterial stimulation may not regulate K Ca function in middle cerebral arteries, as increases in stretch-induced tension did not alter SK Ca input (McNeish et al., 2006) . However, basal release of NO suppresses myogenic tone and an ability to elaborate NO is associated with maintained SK Ca input to EDHF-evoked hyperpolarization in this artery. It is only after inhibition of NO synthase that the contribution of SK Ca is lost, with EDHF responses becoming entirely reliant on IK Ca (McNeish et al., 2005 , McNeish et al., 2006 .
Although NO may suppress EDHF activity under some circumstances, these two separate dilator pathways do operate simultaneously in many arteries, including the rat middle cerebral artery (Zygmunt et al., 1998 , Feletou and Vanhoutte, 2006 , McNeish et al., 2006 , but it is not clear how NO may alter SK Ca activity. In non-vascular smooth muscle from the rat, there is evidence that NO can directly stimulate SK Ca channel function (Geeson et al., 2002) . Basal release of NO may also protect SK Ca channel function indirectly. For example, NO may suppress an inhibitory mediator for the SK Ca channel (and thus the EDHF response) such as the potent vasoconstrictor 20-HETE. 20-HETE does inhibit the EDHF response in small porcine coronary arteries (Randriamboavonjy et al., 2005) and NO can inhibit the synthesis of 20-HETE, by binding to the heme group of cytochrome P450 (CYP450) (Minamiyama et al., 1997) . Another mediator that could potentially affect the EDHF response and in particular the SK Ca channel is thromboxane A 2 (TxA 2 ). In rat mesenteric resistance arteries, stimulation of TxA 2 receptors (TP receptors) with U46619 attenuates SK Ca function (Crane and Garland, 2004) . NO has also been shown to inhibit the synthesis of TxA 2 , again by an interaction with a heme active site, this time in thromboxane synthase (Wade and Fitzpatrick, 1997) . Indeed, increased TxA 2 signalling has been reported to contribute to vasoconstriction and the development of vasomotion induced in middle cerebral arteries by NO synthase inhibitors (Lacza et al., 2001 , Benyo et al., 1998 . Finally, NO may also affect K Ca function via indirect cGMP mediated effects. So, for example, NO/cGMP causes desensitisation of TP receptors via a protein kinase G (PKG) dependent mechanism (Reid and Kinsella, 2003) .
Therefore we hypothesised that constriction following inhibition of NOS and the associated loss of the SK Ca component of agonist induced hyperpolarization may be underpinned by an increase in the synthesis and/or function of TxA 2 or 20-HETE in the rat middle cerebral artery. The aim of the present study was therefore to assess the contribution of K Ca channel subtypes to hyperpolarization and relaxation in rat middle cerebral artery smooth muscle cells by stimulating the endothelium with the PAR2 receptor agonist, SLIGRL; SLIGRL was the only agent used to stimulate endothelium dependent responses as other mediators such as ACh, ADP and bradykinin elicit, at best, a weak EDHF response in middle cerebral arteries (unpublished data). Subsequently we investigated whether inhibiting TP receptors, thromboxane synthesis or synthesis of 20-HETE can restore the SK Ca component of the EDHF response that is lost after inhibition of NOS. The ability of these treatments to reverse the L-NAME induced depolarisation and constriction was also evaluated. indomethacin (10 M) and the phospholipase A 2 inhibitor, AACOCF 3 (10 M). In some experiments endothelium dependent hyperpolarization was assessed in vessels without L-NAME and still able to synthesise NO. In these experiments, the effect of the K Ca channel blockers was assessed on endothelium-dependent hyperpolarization induced by SLIGRL (20 M) in the presence of the TP receptor agonist U46619 (5 nM). Papaverine (150 M) was added at the end of each experiment to assess overall tone. All drugs were allowed to equilibrate for at least 20min before vasodilator responses were stimulated. In most experiments smooth muscle membrane potential (E m ) and tension were measured simultaneously as previously described, using glass microelectrodes (filled with 2M KCl; tip resistance, 80-120M) to measure E m (Garland and McPherson, 1992) .
Materials and Methods

Data analysis and statistical procedures
Results are expressed as the means.e.mean of n animals. Tension values are given in mN (always per 2mm segment) and E m as mV. Vasodilatation is expressed as percentage reduction of the total vascular tone (myogenic tone plus vasoconstrictor response), quantified by relaxation with papaverine (150M). Graphs were drawn and comparisons made using one-way ANOVA with
Tukeys' post-test (Prism, Graphpad). P≤0.05 was considered significant. 
was a generous gift from Dr H. Wulff (University of California, Davis). All stock solutions (100 mM) were prepared in dimethylsulfoxide (DMSO) except L-NAME, apamin, iberiotoxin, papaverine and SLIGRL which were dissolved in 0.9% NaCl and indomethacin which was dissolved in Na 2 CO 3 (1 M); vehicle controls were performed when necessary.
Results
We have previously reported myogenic tone equivalent to about 14% of the maximal vasoconstriction induced in rat middle cerebral arteries by raising [K + ] o to 55 mM, and that the NO synthase inhibitor, L-NAME (100 M) further contracts the artery to circa 70% of this maximum associated with smooth muscle depolarization of 12.8  0.7 mV (McNeish et al., 2005 ). In the current study, in the presence of L-NAME induced vasoconstriction SLIGRL induced EDHFmediated hyperpolarization and relaxation of 19.6  3.1 mV and 80.9  6.7 % (n=4, respectively).
In agreement with our previous studies, this hyperpolarization and relaxation was abolished by the selective IK Ca channel inhibitor TRAM-34 (to 1.2  0.8 mV and 6.0  1.8%, respectively, n=4).
Effect of inhibiting TP receptors or CYP 450 on L-NAME constriction and EDHF mediated hyperpolarization and relaxation
The TP receptor antagonist ICI 192,605 (100 M) reversed depolarization and contraction to L-NAME (by 12.9  2.9 mV, n=3 and 67.9  6.3%, n=7, respectively), but did not alter the EDHFmediated hyperpolarization (of 18.7  3.8 mV, n=7) and relaxation (73.2  8.5%, n=9) to SLIGRL Similar results were obtained after inhibition of cyclo-oxygenase with 10 µM indomethacin.
Indomethacin did not affect L-NAME induced vasoconstriction or the EDHF response (tone of 5.0  0.6 and 4.7  0.4 mN, n=6 and 11, before and after indomethacin, respectively), but when present TRAM-34 alone only slightly depressed EDHF-mediated hyperpolarization and relaxation (12.1  3.2 and 46.6  10.3%, n=10). However, in combination with apamin these responses were significantly attenuated (7.4 ± 2.0 mV and 35.5 ± 9.3%, respectively, n=6, P<0.05). The residual response was blocked by the addition of iberiotoxin (1.4 ± 1.8 mV and 11.6 ± 3.7%, respectively, n=3, P<0.05; Figure 5 ).
The PLA 2 inhibitor AACOCF 3 (10 µM) reversed L-NAME-induced tone (85.6 ± 3.8%; Figure 6 ) and inhibited EDHF hyperpolarization and relaxation (27.7 ± 6.0 mV and 72.0 ± 7.4%, n=7, versus 9.4 ± 3.5 mV and 32.7 ± 15.0%, n=6, respectively). The residual EDHF response was blocked by TRAM-34 alone (5.6 ± 2.8 mV and 4.5 ± 6.5%, respectively, n=4, P<0.05; Figure 6 ).
Discussion
These data demonstrate that activation of TxA 2 (TP) receptors in the rat middle cerebral artery can explain the absence of SK Ca input to endothelium dependent hyperpolarization when NO synthesis is inhibited. Furthermore, inhibition of NOS may result in an increase in TxA 2 synthesis, as inhibiting TxA 2 synthesis restores SK Ca input as well as uncovering a previously unrecognised role for large conductance calcium activated potassium channels (BK Ca ) in the EDHF response. These results help to explain our previous observation, that NO protects a functional input from SK Ca in the rat middle cerebral artery (McNeish et al., 2006) and provide a link to our demonstration that the stimulation of TP receptors inhibits SK Ca function Garland, 2004, Plane and Garland, 1996) .
EDHF responses in the rat middle cerebral artery are unusual, in being dependent only on activation of IK Ca . In most vessels that exhibit an EDHF response, inhibition of both SK Ca and IK Ca channels is necessary to block the EDHF response (Busse et al., 2002) . Despite this difference, the rat middle One possibility, is an alteration in the synthesis of 20-HETE a potent vasoconstrictor derived from arachidonic acid by cytochrome P450 (CYP 450)-dependent enzymes. 20-HETE is involved in myogenic constriction/autoregulation in cerebral vessels (Gebremedhin et al., 2000 , Harder et al., 1994 and is also known to inhibit EDHF mediated responses by reducing K Ca function in small coronary arteries (Randriamboavonjy et al., 2005) . Furthermore, synthesis of 20-HETE can be inhibited by NO binding to the heme active site of its synthetic enzyme (Minamiyama et al., 1997) .
However, despite the fact that 20-HETE has a role in myogenic tone we failed to demonstrate any input to cerebral constriction after inhibition of NOS. The non-selective CYP 450 inhibitor 17-ODYA, did not alter the L-NAME induced constriction in the middle cerebral artery. Furthermore, 17-ODYA also failed to reveal any functional role for the SK Ca channel in the EDHF response, as TRAM-34 alone was still able to abolish this response. This suggests that NO does not normally protect SK Ca channel function by inhibiting the synthesis/function of 20-HETE or a related metabolite generated by CYP 450-dependent enzymes.
Another autacoid that could affect K Ca channel function is the potent vasoconstrictor and platelet activator TxA 2 . As well as being involved in NOS mediated vasoconstriction in rat middle cerebral arteries (Benyo et al., 1998 , Lacza et al., 2001 , Gonzales et al., 2005 , we have previously shown that stimulation of TxA 2 receptors (TP) results in a fairly rapid loss of the SK Ca component of EDHF hyperpolarization and associated relaxation in peripheral arteries of the rat (Crane and Garland, 2004) . NO does inhibit the formation of TxA 2 , by binding to the heme active site of TxA 2 synthase (Wade and Fitzpatrick, 1997) . It may also inhibit cyclo-oxygenase (Kanner et al., 1992) , responsible for synthesising the precursor of TxA 2 (and other prostaglandins), PGH 2 . In addition to inhibiting synthesis, NO is also known to desensitise the TP receptor through a PKG-dependent mechanism (Reid and Kinsella, 2003) . In the present study, L-NAME induced constriction was significantly reduced by the TP receptor antagonist, ICI 192,605, indicating that receptor activation might account for at least some of the constriction following inhibition of NOS. In contrast, a structurally unrelated TP receptor antagonist SQ 29,548 failed to alter L-NAME induced constriction, suggesting that ICI 192,605 may have been acting non-selectively. Indeed, the concentration of ICI 192,605 used in this study (100 M) is known to have effects on PGE 2 (EP) receptors, which may provide an explanation (Brewster et al., 1988) . However, in vessels pretreated with L-NAME, both of the TP receptor antagonists uncovered a functional role for the SK Ca channel in the EDHF response. Simultaneous block of both SK Ca and IK Ca channels with apamin and TRAM-34 was necessary to abolish the response as the functional ability of either channel appeared sufficient to elicit adequate hyperpolarization for full EDHF mediated relaxation.
Therefore, stimulation of TP receptors could explain the loss of the SK Ca dependent component of endothelium dependent hyperpolarization after inhibition of NOS. This suggestion is supported by the observation that activation of TP receptors with U46619 abolishes the SK Ca component of endothelium dependent hyperpolarization, in arteries still able to synthesise NO. NO dependent inhibition of TP receptors appears to depend on activation of PKG (Reid and Kinsella, 2003) , which may explain our previous observation that ODQ (1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one) , an inhibitor of soluble guanylate cyclase, revealed endothelium dependent hyperpolarization mainly dependent upon IK Ca (McNeish et al., 2006) . The possible involvement of cGMP mediated effects in the regulation of SK Ca channel function is a subject of ongoing investigation.
As stimulation of TP receptors appeared to account for the loss of SK Ca function in arteries treated with a NOS inhibitor, we investigated if receptor stimulation reflected an increased synthesis of TxA 2 (or its precursor PGH 2 , which can also stimulate these receptors) as opposed to an inhibitory action of NO/cGMP dependent signalling on TP receptors. The former appeared to be the case, as inhibition of TxA 2 synthase with furegrelate or inhibition of cyclo-oxygenase (to inhibit synthesis of PGH 2 and thus TxA 2 ) with indomethacin each revealed a role for SK Ca channels in the EDHF response. Neither treatment had any effect on the L-NAME induced constriction, again indicating that stimulation of TP receptors does not form a major component of this response.
Interestingly, pre-treatment with either indomethacin or furegrelate also revealed a role for BK Ca in the EDHF response. The explanation for this unexpected observation is the subject of ongoing investigation. One possibility is that altering the prostanoid profile in the vessel wall uncovers an eicosanoid pathway able directly to activate BK Ca on the smooth muscle cells in this artery (McNeish et al., 2006) .
The observation that stimulation of either TP receptors or 20-HETE did not appear to contribute to the contraction following inhibition of NOS was surprising, as both signalling pathways have previously been implicated in this response (Benyo et al., 1998 , Lacza et al., 2001 , Harder et al., 1994 . However, our data do indicate that constriction involves a metabolite of arachidonic acid, as the PLA 2 inhibitor AACOCF 3 fully reversed L-NAME-induced constriction. Interestingly, the EDHF response was also attenuated by inhibition of PLA 2 , which is consistent with previous observations in the rat middle cerebral artery (You et al., 2002) . However, a significant EDHF response remained after treatment with AACOCF 3 and was abolished by TRAM-34. Overall, these observations suggest there are at least two components of the EDHF response in the rat middle cerebral artery. One component appears to involve a metabolite of arachidonic acid. A recent study by You et al. (2005) appears to rule out the involvement of metabolites of either the lipoxygenase (EETs) or epoxgenase pathways (HETEs) in rat middle cerebral arteries (You et al., 2005) , so the identity of such an active metabolite remains uncertain. Other components of the EDHF response appear to rely solely upon the activation of endothelial K Ca channels, and may lead to smooth muscle hyperpolarization/relaxation through an increase in extracellular [K + ] (McNeish et al., 2005) and/or a direct transfer of hyperpolarization via myoendothelial gap junctions (McNeish et al., 2006 , Sokoya et al., 2006 . Hatched lines represent the control membrane potential and tension before addition of AACOCF3. AACOCF3 relaxed the L-NAME-induced tone as well as attenuating the EDHF response, the residual EDHF response was completely blocked by TRAM-34 alone. Parallel lines (//) indicate a time break between separate recordings from a single vessel.
